Full Text View
Tabular View
No Study Results Posted
Related Studies
Study on Clinical Effectiveness and Safety of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) at Different Dosage in Korean Patients
This study has been completed.
Study NCT00613327   Information provided by Janssen Korea, Ltd., Korea

First Received on January 31, 2008.   Last Updated on April 26, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Overactive Bladder
Additional conditions recognized in this trial
Urinary Bladder, Overactive
More general conditions related to this trial
Signs and Symptoms
Urinary Bladder Diseases
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Oxybutynin
Additional drug interventions recognized in this trial
Mandelic Acids
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Infective Agents, Urinary
Autonomic Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
Janssen Korea, Ltd., Korea


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services